GlassScriptPhysician profile
Himani Goyal
NPI 1467637298
$130,356.41
in general payments reported to CMS, 2019-2025
29 companies · $91K in 2025
The $91K reported for 2025 was more than what 99% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,401 · 2020: $2,245 · 2021: $1,678 · 2022: $7,972 · 2023: $2,489 · 2024: $23K · 2025: $91K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $65K · Consulting Fee: $38K · Food and Beverage: $9,051 · Travel and Lodging: $4,504 · Honoraria: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $64,575.00 |
| Consulting Fee | $38,430.95 |
| Food and Beverage | $9,051.07 |
| Travel and Lodging | $4,503.71 |
| Honoraria | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $87,206.42 | 2024-2025 | Xdemvy |
| Glaukos Corporation | $15,701.53 | 2019-2025 | Epioxa, Travoprost Intraocular Implant - Idose, Idosetr |
| Alcon Vision LLC | $4,843.87 | 2019-2025 | Clareon, Acrysof Iq Vivity, Ngenuity |
| Bausch & Lomb Americas INC. | $4,462.05 | 2024-2025 | Xiidra, Miebo, Envista Aspire Iol |
| Alcon Research LLC | $3,490.00 | 2022-2024 | |
| Carl Zeiss Meditec, INC. | $3,113.52 | 2020-2022 | |
| Carl Zeiss Meditec Cataract Technology INC. | $2,137.98 | 2019-2023 | |
| Oyster Point Pharma, INC. | $1,520.08 | 2022-2024 | Tyrvaya |
| Sight Sciences, INC. | $1,012.08 | 2019-2025 | Omni Surgical System |
| Johnson & Johnson Surgical Vision, INC. | $956.43 | 2019-2024 | Tecnis Iol, Tecnis Simplicity, Star S4 Ir |
| Abbvie INC. | $815.60 | 2022-2025 | |
| Sun Pharmaceutical Industries INC. | $660.74 | 2021-2025 | Cequa |
| Topcon Healthcare, INC. | $595.09 | 2024 | |
| New World Medical,INC. | $587.41 | 2020-2023 | |
| Harrow Eye, LLC | $581.31 | 2024-2025 | Vevye |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $462.25 | 2023 | Tecnis Simplicity, Sovereign Compact |
| Eyevance Pharmaceuticals LLC | $459.43 | 2021 | |
| Ocular Therapeutix, INC. | $384.82 | 2019-2025 | Dextenza |
| Dompe US, INC. | $333.95 | 2020-2024 | Oxervate |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $300.24 | 2019-2021 | |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $187.22 | 2024 | |
| Mallinckrodt Hospital Products INC. | $180.92 | 2021-2025 | Acthar |
| Aerie Pharmaceuticals, INC. | $124.37 | 2019 | |
| Biotissue Holdings INC. | $80.88 | 2024 | |
| Thea Pharma INC. | $49.44 | 2023 | |
| Carl Zeiss Meditec USA, INC. | $38.28 | 2022 | |
| Novartis Pharmaceuticals Corporation | $36.70 | 2020 | |
| Ivantis, INC | $19.19 | 2020 | |
| Endo Pharmaceuticals INC. | $14.61 | 2024 | Xiaflex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Himani Goyal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.